PE Guidelines logo
Pharmacoeconomic Guidelines Around The World

Country/Region: Cuba

PE Guidelines
Methodological Guidelines for Health Economic Evaluation (2003)
PDF in Spanish

PE Guidelines Source:
Cuba Ministry of Health

Additional Information:

Last Webpage Update: Tuesday, January 16, 2018

PE Guidelines Key Features:

Key Features:  
Title and year of the documentMethodological Guidelines for Health Economic Evaluation (2003) 
Affiliation of authorsMinistry of Public Health, Nevalat Project, National School of Public Health MA in Economics 
Purpose of the documentProvide recommendations for the conduction of studies to yield transparent, comparable, valid and credible results and facilitate researchers that have less experience in the subject with information on how to complete an economic evaluation. 
Standard reporting format includedYes 
Target audience of funding/ author's interestsTo those who conduct PE evaluations or evaluate PE studies (decision-makers) 
PerspectiveSociety, government, patient perspective 
IndicationApproved Indication 
Target populationClearly specified 
Subgroup analysisWhen necessary 
Choice of comparatorMost prevalent treatment, most used treatment 
Time horizonYes, recommendations given. 
Assumptions requiredYes 
Preferred analytical techniqueCBA, CEA, CMA, CUA 
Costs to be includedAll relevant cost data should be clearly identified and explained in details. 
Source of costsMust be referenced and identified to relate to the relevance of costs data (i.e. databases). 
Systematic review of evidencesYes, encourage meta-analysis 
Preference for effectiveness over efficacyYes, effectiveness must be a part of every and all studies. 
Preferred outcome measureEffectiveness 
Preferred method to derive utilityN/A 
Equity issues statedYes 
Discounting costsYes, use rates recommended by specific governement agencies. 
Discounting outcomesYes, rates explained. 
Sensitivity analysis-parameters and rangeFor all uncertain parameters, a plausible range must be defined for each parameter. 
Sensitivity analysis-methodsOne-way, multi-way, probabilistic analysis when adequate. 
Presenting resultsThe results should be presented in a detailed, clear and transparent manner, so that if possible apply the findings within the country as well as in other countries. 
Incremental analysisYes 
Total costs vs effectiveness (cost/effectiveness ratio)Yes 
Portability of results (Generalizability)Yes 
Financial impact analysisYes 
Mandatory or recommended or voluntaryRecommended 

Acknowledgement: Ana Pazmiņo contributed to the key feature form.

Country Selection Page | PE Guidelines Index Page